	Redox Metabolism and Metabolic Vulnerabilities in Diabetes-Driven Pancreatic Cancer: Targeting System Xc(-), mTORC1, and Disulfidptosis as Therapeutic Strategy. Cell Biochem Funct Raj FJ, Solomonraj AR, Thangaraj P. PMID: 42389908 [PubMed - indexed for MEDLINE]
	Bioengineering advances in pancreatic cancer organoids for reproducible tumor microenvironment modeling. iScience Chen R, Yin B, Zhang Y, Peng J, Guo X, Wu W. PMID: 42389605 [PubMed]
	Peritoneal metastasis in pancreatic cancer: molecular mechanisms, microenvironmental remodeling, and emerging intraperitoneal interventions. Front Mol Biosci Chen J, Li K, Zou Y, Yang J, Xing L, Xiao K. PMID: 42388567 [PubMed]
	Obesity-driven extracellular vesicle signaling in cancer: mechanistic insights and clinical implications. Oncogenesis Chakrapani LN, Velasquez J, Suresh J, Sridhar SD, Sankaran R, Arivazhagan SP, Shanmugam A, Dorayappan KDP, O'Malley DM, Muthusamy T, Selvendiran K. PMID: 42386697 [PubMed - as supplied by publisher]
	Robotic versus Open Pancreatoduodenectomy (PORTAL): multicentre, single masked, phase 3, non-inferiority randomised controlled trial. BMJ Jin J, Qin K, Gemenetzis G, Wang Z, Zheng C, Li W, Wu Z, Shi Y, Chen M, Qian J, Weng Y, Chen W, Jin W, Jin R, Li J, Liu L, Chen Y, Han B, Liang X, Sun C, Wu Z, Mou Y, Yin X, Deng X, Peng C, He T, Song Y, Shen B. PMID: 42386316 [PubMed - indexed for MEDLINE]
	NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial. ESMO Open Kahl T, Eisenring SD, Liposits G. PMID: 42385673 [PubMed - as supplied by publisher]
	Perioperative tislelizumab for early-stage hepatocellular carcinoma: A phase II trial with integrated tumour microenvironment profiling and predictive modeling. Drug Resist Updat Chen L, Han R, Zhai S, Wang Y, Ma X, Cao Z, Li G, Zhang S, Gong W, Hao J, Song T. PMID: 42385524 [PubMed - as supplied by publisher]
	Longitudinal assessment of health-related quality of life in patients with borderline and locally advanced pancreatic cancer undergoing neoadjuvant FOLFIRINOX chemotherapy: results from a prospective multicenter trial. Langenbecks Arch Surg de Carvalho LFA, Ceelen W, Meertens A, Rashidian N, Waked B, Geboes K, Ribeiro S, Gorleer K, Dedecker H, Triest L, Vervaecke A, Sas S, Sierens B, Beyls C, Sie M, van Dijk M, Verhaeghe N, Berrevoet F. PMID: 42384236 [PubMed - as supplied by publisher]
	Evaluation of Gd-EOB-DTPA MRI With Diffusion and Clinicopathologic Features for Predicting Microvascular Invasion in Hepatocellular Carcinoma. J Comput Assist Tomogr Zhang N, Sun H, Ge M, Zhou P. PMID: 42383894 [PubMed - as supplied by publisher]
	A HRH1-YAP1 feedback loop drives pancreatic cancer progression and predicts therapeutic response. Oncol Lett Chen J, Wen J. PMID: 42383289 [PubMed]
	Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer. Front Immunol Zhu H, Yi W, Wu Y, Li R, Zhou B. PMID: 42382771 [PubMed - indexed for MEDLINE]
	A Single Institution Experience with Pancreatic Carcinoma: A Retrospective Study. Indian J Surg Oncol Trivedi S, Varun M, Bharadwaj A, Patel S, Sharma M, Warikoo V, Puj K, Salunke A, Tripathi U, Pandya S. PMID: 42381806 [PubMed]
	Pancreatic Cancer: Translating Tumor Biology into Actionability. Cancer Discov Balogun FO, Sherman MH, Park W, Soares KC, Reyngold M, Schoenfeld JD, Singhal A, Iacobuzio-Donahue CA, O'Reilly EM. PMID: 42381464 [PubMed - indexed for MEDLINE]
	Cardiovascular-Kidney-Metabolic Syndrome, Healthy Lifestyles, and Risk of Cancer Incidence and Mortality: A Prospective Cohort Study. Int J Cancer Qie R, Liu H, Liu Y, Guo X, Chen Q, Xu H, Wang X, Kang R, Cheng C, Zhao M, Wang H, Zheng L, Liu S, Zhang S. PMID: 42381231 [PubMed - as supplied by publisher]
	Impact of reinforced pancreaticojejunostomy with or without tissue adhesive glue modified cyanoacrylate following pancreaticoduodenectomy: a randomized controlled clinical trial. World J Surg Oncol Saleh SK, Farahat MS, Mohamed TA, Hendy MM. PMID: 42381068 [PubMed - indexed for MEDLINE]
	Defining the Incremental Value of Endoscopic Ultrasound in Assessing Pancreatic Cystic Neoplasms. Ann Surg Tocci NX, Deverakonda DL, Schmidt EM, Ansari P, Wehrle CJ, Allkushi E, Bennett WC, Tu C, Perlmutter B, McMichael J, Augustin T, Naffouje S, Joyce D, Naples R, Simon R, Walsh RM. PMID: 42381052 [PubMed - as supplied by publisher]
	Clinical Implementation Gap of Comprehensive Genomic Profiling in Pancreatic Cancer: A Real-world Study. In Vivo Ando M, Inoue T, Iwata T, Kubo A, Fukami Y, Sano T. PMID: 42379797 [PubMed - indexed for MEDLINE]
	Impact of Cirrhosis Outcome Risk Estimator Score on Outcomes Following Pancreatectomy for Resectable Pancreatic Ductal Adenocarcinoma. In Vivo Yasui K, Takagi K, Fuji T, Nishiyama T, Okada N, Fujiwara T. PMID: 42379784 [PubMed - indexed for MEDLINE]
	Log-transformed α-Fetoprotein and Des-γ-carboxy Prothrombin Predict Early Recurrence After Hepatectomy for Hepatocellular Carcinoma. In Vivo Nakanishi K, Shinkawa H, Yoshida H, Kinoshita M, Watanabe G, Nishio K, Kimura K, Ishizawa T. PMID: 42379778 [PubMed - indexed for MEDLINE]
	Computed Tomography-based Assessment of Visceral Fat for Predicting Intra-abdominal Infectious Complications After Gastrectomy in Patients With Gastric Cancer. In Vivo Hashimoto I, Maezawa Y, Tamagawa A, Nojima K, Hatayama R, Uchiyama M, Kato A, Atsumi Y, Kazama K, Kawabe T, Saito A, Yukawa N. PMID: 42379774 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 60703

Page 1 of 3036



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy